PAR2 agonists for use in the treatment or prevention of influenza virus type A infections

• 收藏
• 分享

专利权人:

Beatrice Riteau;Nathalie Vergnolle

发明人:

Nathalie Vergnolle,Beatrice Riteau

申请号：

US13266799

公开号：

US09125861B2

申请日:

2010.05.03

申请国别(地区):

US

年份:

2015

代理人:

摘要：

Methods and compositions (such as pharmaceutical compositions) for treating influenza virus type A infections in human subjects include PAR2 agonists being administered to the subject. The PAR2 agonists include small organic molecules, antibodies, and aptamers. In addition, the PAR2 agonist may be a PAR2 activating peptide. Exemplary PAR2 activating peptides include SLIGRL (SEQ ID NO: 1) and SLIGKV (SEQ ID NO: 2).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/